Researchers from Los Angeles-based Cedars-Sinai and the University of Pennsylvania in Philadelphia used a nationwide database to analyze the medical records of 45 million individuals with at least one outpatient or inpatient visit from 2011-23. They found about 1 million new GLP-1 users during this time, and classified them based on whether they had diabetes, obesity or other related conditions.
Here’s a breakdown of the shifts researchers observed:
- An average of nearly 65% of GLP-1 users had Type 2 diabetes between 2011-14, and nearly 47% had a body mass index of 30 or higher.
- Between 2019 and 2023, patterns shifted, with a greater share of new GLP-1 prescriptions being written for obesity. More than 66% of prescriptions for new users in that period were for patients with a BMI of at least 30, and 54% were for patients who had Type 2 diabetes.
“This data suggests that more healthcare providers are seeing the benefits of these medications for treating obesity, which is a significant public health shift,” Yee Hui Yeo, MD, an author on the study and clinical fellow in the Karsh Division of Gastroenterology and Hepatology at Cedars-Sinai, said in a news release. “However, it also raises concerns about potential medication shortages and the need to ensure that patients with diabetes still have access to these treatments.”
Prescription volumes for GLP-1 medications surged 300% between 2020 and 2022, leading to supply shortages. Read more about trends affecting the supply of GLP-1 drugs here.
Readers interested in the effects of GLP-1s on health systems and questions about their role in care delivery over the next 18 months are invited to join Becker’s for a complimentary editorial webinar on this topic. Sign up here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.